These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 30701345

  • 1. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS, Windsor A, Cohen R, Chand M.
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [Abstract] [Full Text] [Related]

  • 2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK, Rutter MD.
    World J Gastroenterol; 2012 Aug 07; 18(29):3839-48. PubMed ID: 22876036
    [Abstract] [Full Text] [Related]

  • 3. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    Da Cunha T, Vaziri H.
    J Clin Gastroenterol; 2024 Jan 01; 58(1):1-11. PubMed ID: 37548445
    [Abstract] [Full Text] [Related]

  • 4. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L.
    J Dig Dis; 2016 Jun 01; 17(6):383-91. PubMed ID: 27129893
    [Abstract] [Full Text] [Related]

  • 5. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, Fidder HH, Siersema PD, Dekker E, Oldenburg B.
    Am J Gastroenterol; 2015 Jul 01; 110(7):1014-21. PubMed ID: 25823770
    [Abstract] [Full Text] [Related]

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Jul 01; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 7. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE, Kuipers EJ, van Haastert M, Nicolaï JJ, Poen AC, van der Woude CJ.
    J Gastroenterol; 2012 Dec 01; 47(12):1308-22. PubMed ID: 22627504
    [Abstract] [Full Text] [Related]

  • 8. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L, Miheller P, Tulassay Z.
    Dig Dis; 2007 Dec 01; 25(3):267-9. PubMed ID: 17827953
    [Abstract] [Full Text] [Related]

  • 9. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.
    Gastroenterol Clin Biol; 2009 Jun 01; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [Abstract] [Full Text] [Related]

  • 10. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
    Bye WA, Nguyen TM, Parker CE, Jairath V, East JE.
    Cochrane Database Syst Rev; 2017 Sep 18; 9(9):CD000279. PubMed ID: 28922695
    [Abstract] [Full Text] [Related]

  • 11. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C, Jensen MD, Fallingborg J, Jess T, Langholz E, Meisner S, Andersen NN, Riis LB, Thomsen OØ, Tøttrup A.
    Dan Med J; 2015 Jan 18; 62(1):B4995. PubMed ID: 25557336
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A, Polyak S, Draganov PV.
    World J Gastroenterol; 2009 Jan 07; 15(1):61-6. PubMed ID: 19115469
    [Abstract] [Full Text] [Related]

  • 13. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR.
    Rev Gastroenterol Disord; 2002 Jan 07; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [Abstract] [Full Text] [Related]

  • 14. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N, Yee E, Feuerstein JD.
    Dig Dis Sci; 2016 Apr 07; 61(4):980-9. PubMed ID: 26646250
    [Abstract] [Full Text] [Related]

  • 15. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J, Ekbom A, Hammar U, Hultcrantz R, Forsberg AM.
    Gut; 2019 Sep 07; 68(9):1588-1596. PubMed ID: 30554159
    [Abstract] [Full Text] [Related]

  • 16. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR, Weizman AV.
    Expert Rev Anticancer Ther; 2014 Jul 07; 14(7):847-56. PubMed ID: 24621115
    [Abstract] [Full Text] [Related]

  • 17. Surveillance strategies in inflammatory bowel disease.
    Schmidt C, Bielecki C, Felber J, Stallmach A.
    Minerva Gastroenterol Dietol; 2010 Jun 07; 56(2):189-201. PubMed ID: 20485256
    [Abstract] [Full Text] [Related]

  • 18. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM.
    Inflamm Bowel Dis; 2012 Dec 07; 18(12):2247-51. PubMed ID: 22467511
    [Abstract] [Full Text] [Related]

  • 19. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B, Savarino E, Verstockt B, Fumery M, Pugliese D, Bertani L, Buda A, Dragoni G, Goren I, Laish I, Spinelli A, Teich N, Truyens M, Ellul P.
    J Crohns Colitis; 2022 Dec 05; 16(12):1845-1852. PubMed ID: 35771951
    [Abstract] [Full Text] [Related]

  • 20. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.